Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01164189 |
|---|---|
| Brief Title: | Bevacizumab in Recurrent Grade II and III Glioma (TAVAREC) |
| First Submitted : | July 15, 2010 |
| First Submitted that Met QC Criteria : | July 15, 2010 |
| First Posted : | July 16, 2010 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 27, 2019 |
| Last Update Posted : | February 28, 2019 |